Related Experiment Video
Updated: May 9, 2026

Orienteering as a Tool for Cognitive Research: An Implementation Guide
Published on: November 29, 2024
ROADMAP and ORIENTAL Trials: the Re-emergence of J-Curve Ghost?
Yoshiyuki Hamamoto1, Hiroyuki Koshiyama
1Center for Diabetes and Endocrinology, The Tazuke Kofukai Foundation Medical Institute Kitano Hospital, Osaka, Japan.
Abstract:
It still remains unknown whether angiotensin-receptor blockers (ARBs) are cardioprotective in patients with type 2 diabetes. The recent two clinical trials, the ROADMAP and the ORIENT, have suggested that fatal cardiovascular events or cardiovascular deaths were unexpectedly higher in olmesartan group. These results suggest that aggressive blood pressure lowering may cause a higher risk in some high-risk patients, especially in those with preexisting coronary heart disease, indicating a possibility that the J-curve phenomenon may exist in some group of patients.
Insights
The cardioprotective effects of angiotensin-receptor blockers (ARBs) in type 2 diabetes patients remain unclear. Some trials suggest higher cardiovascular risks with aggressive blood pressure lowering, possibly indicating a J-curve phenomenon in high-risk individuals.
Area of Science:
- Cardiology
- Endocrinology
- Pharmacology
Background:
- Cardioprotection by angiotensin-receptor blockers (ARBs) in type 2 diabetes is not well-established.
- Type 2 diabetes is a significant risk factor for cardiovascular disease.
Purpose of the Study:
- To investigate the cardioprotective potential of ARBs in patients with type 2 diabetes.
- To analyze cardiovascular event rates in ARB treatment groups.
Main Methods:
- Review of recent clinical trials, specifically the ROADMAP and ORIENT studies.
- Analysis of cardiovascular outcomes, including fatal events and deaths, in patients treated with olmesartan.
Main Results:
- Unexpectedly higher rates of fatal cardiovascular events and cardiovascular deaths were observed in the olmesartan group.
- These findings suggest a potential increased risk associated with aggressive blood pressure lowering in certain patient subgroups.
Conclusions:
- Aggressive blood pressure lowering with ARBs may increase cardiovascular risk in high-risk patients, particularly those with coronary heart disease.
- The J-curve phenomenon, where very low blood pressure is associated with increased risk, may be relevant in this population.
Related Concept Videos
Survival Curves
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
Horizontal Curve: Problem Solving
Vertical Curve: Problem Solving
Orthogonal Trajectories
Crossover Experiments
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Interpreting Run Charts
